Abvc Biopharma (ABVC) Other financing activities (2023 - 2026)

Abvc Biopharma (ABVC) has reported Other financing activities for 4 consecutive years, with -$217492.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other financing activities changed N/A year-over-year to -$217492.0; the trailing twelve-month figure through Jun 2026 stood at $3.0 million (up 210.4% YoY), and the FY2025 full-year result was $3.3 million, up 248.84% from the prior year.
• Other financing activities retreated to -$217492.0 in Q2 2026 per ABVC's latest filing, from $319492.0 in the prior quarter.
• Across five years, Other financing activities topped out at $2.4 million in Q3 2025 and bottomed at -$217492.0 in Q2 2026.
• Historically, Other financing activities has averaged $481345.9 across 4 years, with a median of $343429.0 in 2024.
• The sharpest annual moves came in 2024 and 2026: Other financing activities soared 1025.52% in 2024, then retreated 22.39% in 2026.
• Over 4 years, Other financing activities stood at -$22690.0 in 2023, then jumped by 1025.52% to $210000.0 in 2024, then surged by 151.52% to $528183.0 in 2025, then slumped by 141.18% to -$217492.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered -$217492.0, $319492.0, and $528183.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.